Metoclopramide Accord

Metoclopramide, the active ingredient in Metoclopramide Accord, is a dopamine D2 receptor antagonist presented as an oral dosage form for oral use. It is employed to relieve nausea and vomiting, to improve gastric emptying in gastroparesis, and to increase lower esophageal sphincter tone in gastro‑esophageal reflux disease.

GNH USA supplies Metoclopramide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that trigger nausea, gastric motility and lower esophageal sphincter tone. It is indicated for several gastrointestinal and emetic conditions. - Nausea and vomiting: reduces episodes by blocking dopamine receptors in the chemoreceptor trigger zone. - Gastroparesis: enhances gastric emptying and improves symptoms of delayed stomach emptying. - Gastro‑esophageal reflux disease (GERD): increases lower esophageal sphincter tone, helping to reduce reflux episodes.

Metoclopramide may cause a range of adverse reactions, from mild to serious. Patients should be aware of both common and less frequent side effects.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements, potentially irreversible. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe allergic reactions: rash, swelling, or difficulty breathing. - Hyperprolactinemia: elevated prolactin levels causing hormonal disturbances.

Before prescribing Metoclopramide, clinicians should consider several safety measures. - Assess renal function: dose adjustment may be needed in impaired clearance. - Monitor for extrapyramidal symptoms: watch for tremor, rigidity, or abnormal movements. - Use lowest effective dose: limit exposure to reduce risk of tardive dyskinesia. - Avoid in patients with known hypersensitivity to metoclopramide or similar compounds. - Use caution in the elderly: increased susceptibility to central nervous system effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines): may enhance sedation and respiratory depression. - Anticholinergic agents: can reduce pro‑kinetic effect and increase constipation risk. - MAO inhibitors: may potentiate hypertensive reactions.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may increase risk of serotonin syndrome. - Tricyclic antidepressants: may augment anticholinergic side effects and affect cardiac conduction.